Form D Explorer

Form D/A — Reprise Biomedical, Inc.

0001782236-26-000002 · filed Jul 1, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$10,000,000
Reported amount sold
$9,246,100
Minimum investment
$0
Investors
43
Sales commission
$0
Finders' fees
$0

Issuer

Name
Reprise Biomedical, Inc.
CIK
1782236
Entity
Corporation
Jurisdiction
MINNESOTA
Year incorporated
—
Address
17400 Medina Rd., Ste. 100
Plymouth, MN 55447
Phone
763-284-6780

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗